JP2000502700A - セフディニルの製造方法 - Google Patents
セフディニルの製造方法Info
- Publication number
- JP2000502700A JP2000502700A JP9524230A JP52423097A JP2000502700A JP 2000502700 A JP2000502700 A JP 2000502700A JP 9524230 A JP9524230 A JP 9524230A JP 52423097 A JP52423097 A JP 52423097A JP 2000502700 A JP2000502700 A JP 2000502700A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- formula
- dimethylacetamide
- reaction
- cefdinir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.下記の式(II) (式中、Phはフェニルを、p−TsOHはp−トルエンスルホン酸を、またD MACはN,N−ジメチルアセトアミドを表す。) のセフディニル中間体のトリチル保護基を酸の存在下で除去することを特徴とす る、下記の式(I) のセフディニルの製造方法。 2.酸が無機酸、有機酸、または酸性水素イオン交換樹脂である請求項1記載の 製造方法。 3.無機酸が塩酸、臭化水素酸、ヨウ化水素酸、硫酸及びルイス酸よりなる群か ら選ばれる請求項2記載の製造方法。 4.ルイス酸が三フッ化ホウ素、三フッ化ホウ素エチルエテレート、塩化アルミ ニウム、五塩化アンチモン、塩化第一鉄、塩化スズ、四塩化チタン及び塩化亜鉛 よりなる群から選ばれる請求項3記載の製造方法。 5.有機酸が酢酸、ギ酸、トリフルオロ酢酸、メタンスルホン酸、ベンゼンスル ホン酸及びp−トルエンスルホン酸よりなる群から選ばれる請求項2記載の製造 方法。 6.ルイス酸または有機酸を用いる場合において、陽イオン捕捉剤の存在下で反 応を行う請求項2記載の製造方法。 7.陽イオン捕捉剤がアニソールである請求項6記載の製造方法。 8.酸を式(II)の化合物に対して1〜20当量の量で用いる請求項1記載の製 造方法。 9.下記の式(II)を有する結晶性セフディニル中間体。 式中、 Phはフェニルを、 p−TsOHはp−トルエンスルホン酸を、 DMACはN,N−ジメチルアセトアミドを表す。 10.下記の表1のX線粉末回折パターンを示す請求項9記載の式(II)の中間体 。 表1.上記の表1で“θ”は回折角を、“d”は格子面間の距離を表し、 “I/Io”は相対強度を表す。 11.下記の式(III)(式中、Zは、 を表し、ここでR′はC1〜C4アルキルまたはフェニルを表し,又は、それらに 付着している酸素及び燐の原子とともに5〜6員複素環を形成することができる 。) の反応性エステルを、溶媒中で塩基の存在下または不存在下で下記の式(IV) の3−セフェム誘導体と反応させた後、p−トルエンスルホン酸を添加すること を特徴とする、下記の式(II) (式中、Phはフェニルを、p−TsOHはp−トルエンスルホン酸を、DMA CはN,N−ジメチルアセトアミドを表す。) の化合物の製造方法。 12.式(IV)の3−セフェム誘導体に対して式(III)の反応性エステルを0. 8〜2.0当量の量で用いる請求項11記載の製造方法。 13.溶媒がN,N−ジメチルアセトアミド単独であり、又は、エタノール、メタ ノール、イソプロパノール、ジエチルエーテル、テトラヒドロフラン、ジオキサ ン、塩化メチレン、クロロホルム、アセトニトリル、エチルアセテート及びアセ トンよりなる群から選ばれた1種以上の化合物とN、N−ジメチルアセトアミド の混合物である請求項11記載の製造方法。 14.反応が−15〜40℃の温度範囲で行われる請求項11記載の製造方法。 15.第3級アミンを塩基として用いる請求項11記載の製造方法。 16.第3級アミンがトリエチルアミンまたはトリ−n−ブチルアミンである請求 項15記載の製造方法。 17.N−トリメチルシリルアセトアミドまたはN,O−ビストリメチルシリルア セトアミドを塩基の不存在下で用いる請求項11記載の製造方法。 18.p−トルエンスルホン酸を式(IV)の3−セフェム誘導体に対して1〜3当 量の量で用いる請求項11記載の製造方法。 19.反応後、後処理過程でジエチルエーテル、ジイソプロピルエーテル及びエチ ルアセテートよりなる群から選ばれる1の化合物を反応溶媒に対して2〜6容積 倍用いる請求項11記載の製造方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1995/58694 | 1995-12-27 | ||
KR1019950058695A KR0174431B1 (ko) | 1995-12-27 | 1995-12-27 | 세프디니르의 제조방법 |
KR1995/58695 | 1995-12-27 | ||
KR1019950058694A KR0174432B1 (ko) | 1995-12-27 | 1995-12-27 | 신규한 결정성 세프디니르 중간체 및 그의 제조방법 |
PCT/KR1996/000250 WO1997024358A1 (en) | 1995-12-27 | 1996-12-26 | Process for preparation of cefdinir |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000502700A true JP2000502700A (ja) | 2000-03-07 |
JP3948628B2 JP3948628B2 (ja) | 2007-07-25 |
Family
ID=26631527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52423097A Expired - Lifetime JP3948628B2 (ja) | 1995-12-27 | 1996-12-26 | セフディニルの製造方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US6093814A (ja) |
EP (1) | EP0874853B1 (ja) |
JP (1) | JP3948628B2 (ja) |
AT (1) | ATE218572T1 (ja) |
DE (1) | DE69621649T2 (ja) |
DK (1) | DK0874853T3 (ja) |
ES (1) | ES2175167T3 (ja) |
PT (1) | PT874853E (ja) |
WO (1) | WO1997024358A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001294590A (ja) * | 2000-04-13 | 2001-10-23 | Otsuka Chem Co Ltd | 3−ビニル−セフェム化合物の製造方法 |
JP2006500356A (ja) * | 2002-08-13 | 2006-01-05 | サンド・アクチエンゲゼルシヤフト | セフジニル中間体 |
JP2006501305A (ja) * | 2002-10-01 | 2006-01-12 | アンティビオーティコス エッセ.ピ.ア. | セフジニル中間体塩 |
JPWO2004085443A1 (ja) * | 2003-03-24 | 2006-06-29 | ア・チ・エツセ・ドブフアル・エツセ・ピー・アー | 7−[2−(2−アミノチアゾール−4−イル)−2−ヒドロキシイミノアセトアミド−3−ビニル−3−セフェム−4−カルボン酸(シン異性体)の新規結晶およびその製造方法 |
JP2008189688A (ja) * | 2001-06-05 | 2008-08-21 | Hanmi Pharm Co Ltd | 結晶性セフジニル酸付加塩及びこれを用いたセフジニルの製造方法 |
JP2009249380A (ja) * | 2008-04-04 | 2009-10-29 | Daewoong Pharmaceutical Co Ltd | セフジニルの合成に有用な中間体及びこれを用いるセフジニルの製造方法 |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5883247A (en) * | 1996-06-10 | 1999-03-16 | Hoffmann-La Roche Inc. | Preparation of cephem and isooxacephem derivatives |
AT405283B (de) | 1997-04-04 | 1999-06-25 | Biochemie Gmbh | Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung |
US20080113025A1 (en) * | 1998-11-02 | 2008-05-15 | Elan Pharma International Limited | Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
ITMI20012364A1 (it) * | 2001-11-09 | 2003-05-09 | Antibioticos Spa | Processo di sintesi della cefixima via alchil-o arilsolfonati |
WO2003050124A1 (en) * | 2001-12-13 | 2003-06-19 | Ranbaxy Laboratories Limited | Crystalline cefdinir potassium dihydrate |
MXPA04010627A (es) * | 2002-04-26 | 2005-02-14 | Ranbaxy Lab Ltd | Proceso para la preparacion de cefdinir. |
ITMI20020913A0 (it) * | 2002-04-29 | 2002-04-29 | Acs Dobfar Spa | Nuova forma cristallina del cefdinir |
WO2004104010A1 (en) * | 2003-05-20 | 2004-12-02 | Ranbaxy Laboratories Limited | Crystalline form of cefdinir |
US20040242556A1 (en) * | 2003-06-02 | 2004-12-02 | Ramesh Dandala | Novel crystalline form of cefdinir |
US20050137182A1 (en) * | 2003-06-02 | 2005-06-23 | Ramesh Dandala | Novel crystalline form of cefdinir |
US20050059818A1 (en) * | 2003-09-12 | 2005-03-17 | Duerst Richard W. | Polymorph of a pharmaceutical |
US20050059819A1 (en) * | 2003-09-12 | 2005-03-17 | Duerst Richard W. | Cefdinir pyridine salt |
US20050113355A1 (en) * | 2003-09-12 | 2005-05-26 | Duerst Richard W. | Cefdinir pyridine salt |
US20060142563A1 (en) * | 2004-03-16 | 2006-06-29 | Devalina Law | Crystalline anhydrous cefdinir and crystalline cefdinir hydrates |
US20050209211A1 (en) * | 2004-03-16 | 2005-09-22 | Devalina Law | Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir |
US20060211676A1 (en) * | 2004-03-16 | 2006-09-21 | Devalina Law | Crystalline anhydrous cefdinir and crystalline cefdinir hydrates |
US20060142261A1 (en) * | 2004-03-16 | 2006-06-29 | Devalina Law | Crystalline anhydrous cefdinir and crystalline cefdinir hydrates |
US20060069079A1 (en) * | 2004-09-27 | 2006-03-30 | Sever Nancy E | Stable amorphous cefdinir |
US20050245738A1 (en) * | 2004-05-03 | 2005-11-03 | Lupin Ltd | Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof |
WO2006010978A1 (en) * | 2004-06-30 | 2006-02-02 | Wockhardt Limited | Cefdinir polymorphic forms, and imidazole salt |
WO2006018807A1 (en) * | 2004-08-16 | 2006-02-23 | Ranbaxy Laboratories Limited | Crystalline forms of cefdinir |
WO2006059753A1 (en) | 2004-11-30 | 2006-06-08 | Astellas Pharma Inc. | Novel oral pharmaceutical suspension of cefdinir crystal |
KR20080064990A (ko) * | 2005-10-31 | 2008-07-10 | 테바 파마슈티컬 인더스트리즈 리미티드 | 세프디니르의 제조방법 |
US20070128268A1 (en) * | 2005-12-07 | 2007-06-07 | Herwig Jennewein | Pharmaceutical compositions comprising an antibiotic |
US8466096B2 (en) * | 2007-04-26 | 2013-06-18 | Afton Chemical Corporation | 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions |
ITMI20071628A1 (it) | 2007-08-06 | 2007-11-05 | Acs Dobfar Spa | Sintesi di 3-alchenilcefalosporine e nuovi intermedi utili ad esse correlati |
CN101481383B (zh) * | 2008-12-31 | 2012-01-11 | 杭州奥默医药技术有限公司 | 头孢地尼酸式复盐化合物及制备方法 |
CN102020664B (zh) * | 2010-11-30 | 2012-12-12 | 浙江工业大学 | 一种头孢地尼的合成方法 |
CN103319503A (zh) * | 2013-06-09 | 2013-09-25 | 四川方向药业有限责任公司 | 一种头孢地尼的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK162718C (da) * | 1982-09-30 | 1992-05-11 | Fujisawa Pharmaceutical Co | Analogifremgangsmaade til fremstilling af 7-substitueret-3-vinyl-3-cephemforbindelser |
IL99898A (en) * | 1990-11-09 | 1996-10-31 | Eisai Co Ltd | 7-Noble-3- Compounds Transformed Carbamoylloxy |
TW212181B (ja) * | 1992-02-14 | 1993-09-01 | Hoechst Ag | |
WO1995035020A2 (en) * | 1994-07-22 | 1995-12-28 | Antibioticos S.P.A. | Glutaryl 7-aca derivatives and processes for obtaining them |
-
1996
- 1996-12-26 US US09/068,719 patent/US6093814A/en not_active Expired - Lifetime
- 1996-12-26 WO PCT/KR1996/000250 patent/WO1997024358A1/en active IP Right Grant
- 1996-12-26 AT AT96943357T patent/ATE218572T1/de not_active IP Right Cessation
- 1996-12-26 DE DE69621649T patent/DE69621649T2/de not_active Expired - Lifetime
- 1996-12-26 PT PT96943357T patent/PT874853E/pt unknown
- 1996-12-26 JP JP52423097A patent/JP3948628B2/ja not_active Expired - Lifetime
- 1996-12-26 EP EP96943357A patent/EP0874853B1/en not_active Expired - Lifetime
- 1996-12-26 ES ES96943357T patent/ES2175167T3/es not_active Expired - Lifetime
- 1996-12-26 DK DK96943357T patent/DK0874853T3/da active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001294590A (ja) * | 2000-04-13 | 2001-10-23 | Otsuka Chem Co Ltd | 3−ビニル−セフェム化合物の製造方法 |
JP4544692B2 (ja) * | 2000-04-13 | 2010-09-15 | 大塚化学株式会社 | 3−ビニル−セフェム化合物の製造方法 |
JP2008189688A (ja) * | 2001-06-05 | 2008-08-21 | Hanmi Pharm Co Ltd | 結晶性セフジニル酸付加塩及びこれを用いたセフジニルの製造方法 |
JP2006500356A (ja) * | 2002-08-13 | 2006-01-05 | サンド・アクチエンゲゼルシヤフト | セフジニル中間体 |
JP2006501305A (ja) * | 2002-10-01 | 2006-01-12 | アンティビオーティコス エッセ.ピ.ア. | セフジニル中間体塩 |
JPWO2004085443A1 (ja) * | 2003-03-24 | 2006-06-29 | ア・チ・エツセ・ドブフアル・エツセ・ピー・アー | 7−[2−(2−アミノチアゾール−4−イル)−2−ヒドロキシイミノアセトアミド−3−ビニル−3−セフェム−4−カルボン酸(シン異性体)の新規結晶およびその製造方法 |
JP2009249380A (ja) * | 2008-04-04 | 2009-10-29 | Daewoong Pharmaceutical Co Ltd | セフジニルの合成に有用な中間体及びこれを用いるセフジニルの製造方法 |
Also Published As
Publication number | Publication date |
---|---|
DE69621649T2 (de) | 2002-09-19 |
PT874853E (pt) | 2002-09-30 |
ATE218572T1 (de) | 2002-06-15 |
WO1997024358A1 (en) | 1997-07-10 |
DE69621649D1 (de) | 2002-07-11 |
ES2175167T3 (es) | 2002-11-16 |
US6093814A (en) | 2000-07-25 |
EP0874853B1 (en) | 2002-06-05 |
JP3948628B2 (ja) | 2007-07-25 |
EP0874853A1 (en) | 1998-11-04 |
DK0874853T3 (da) | 2002-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3948628B2 (ja) | セフディニルの製造方法 | |
JP4856795B2 (ja) | セファロスポリン抗生物質の製造における新規な塩 | |
US4866055A (en) | Cephalosporin derivatives and their crystalline derivatives | |
EP0392796A2 (en) | Cephalosporin derivatives | |
JP3143829B2 (ja) | 7−アシル−3−置換カルバモイルオキシセフェム化合物及びその製法 | |
JP2600878B2 (ja) | 7―[2―(2―アミノチアゾール―4―イル)―2―ヒドロキシイミノアセトアミド]―3―セフェム化合物の製造法 | |
KR100342600B1 (ko) | 신규한 티아졸 화합물 및 그의 제조 방법 | |
AU654384B2 (en) | Preparation of a cephalosporin antibiotic using the syn-isomer of a thiazolyl intermediate | |
KR20040007978A (ko) | 9-[4-아세톡시-3-(아세톡시메틸)부트-1-일]-2-아미노푸린의제조방법 | |
US4297279A (en) | Imidazoledicarboxylic acid derivative | |
HU212782B (en) | Water-free acylating process for stereospecifical producing antibioticum cephepim-dihydrochloride-hydrate | |
KR0174432B1 (ko) | 신규한 결정성 세프디니르 중간체 및 그의 제조방법 | |
US5594130A (en) | Preparation of a cephalosporin antibiotic using the syn-isomer of a thiazolyl intermediate | |
WO2003040148A1 (en) | A process for the preparation of cefixime via alkyl-or aryl-sulfonates | |
JPS61122290A (ja) | セフアロスポリン誘導体の製造方法 | |
JPH02117680A (ja) | 3―クロロセファロスポリン骨格を有する化合物 | |
KR0174431B1 (ko) | 세프디니르의 제조방법 | |
US5143911A (en) | Antibiotic c-3 di-hydroxyphenyl substituted cephalosporin compounds, compositions and method of use thereof | |
GB2195334A (en) | 1-Methanesulfonyloxy-6-trifluoromethyl-1H-benzotriazole and its use in preparing cephalosporin derivatives | |
US5831085A (en) | Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof | |
KR100293728B1 (ko) | 결정성세피롬황산염의제조방법 | |
KR101028689B1 (ko) | 신규한 결정성 3-머캅토-1-(아세트이미도일)피롤리딘유도체 및 그의 제조방법 | |
JP2898029B2 (ja) | セフェム誘導体ジメチルホルムアミド溶媒和結晶 | |
JP3005273B2 (ja) | チアゾリルアセトアミド―3―セフェム系誘導体 | |
JP2959821B2 (ja) | チアゾリルアセトアミドセフェム誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070131 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070320 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070413 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100427 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110427 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110427 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110427 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110427 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120427 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120427 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130427 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130427 Year of fee payment: 6 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140427 Year of fee payment: 7 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |